Anti-pneumococcal antibody response in normal subjects: A meta-analysis

Journal of Allergy and Clinical Immunology

Volumn 98, Issue 1, 1996, Pages 205-215

  Go, Eddie S ^a   Ballas, Zuhair K ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

anti polysaccharide antibody; antibody; antibody deficiency; immunodeficiency; meta analysis; pneumococcal vaccine; Streptococcus pneumoniae

Indexed keywords

BACTERIUM ANTIBODY; PNEUMOCOCCUS VACCINE;

ANTIBODY RESPONSE; ARTICLE; HUMAN; IMMUNE DEFICIENCY; META ANALYSIS; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0029739076     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70244-0     Document Type: Article

References (49)

1. Chapel HM. Consensus on diagnosis and management of primary antibody deficiencies. Br Med J 1994;308:581-5.
2. Huston DP, Kavanaugh AF, Rohane PW, Huston MM. Immunoglobulin deficiency syndromes and therapy. J Allergy Clin Immunol 1991;87:1-17.
3. Cooper MD, Chase HP, Lowman JT, Krivitt W, Good RA. Wiskott-Aldrich syndrome: an immunologic deficiency disease involving the afferent limb of immunity. Am J Med 1968;44:499-513.
4. Umetsu DT, Ambrosino DM, Quinti I, Siber GR, Geha RS. Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med 1985;313:1247-51.
5. Koskela M, Leinonen M, Haiva V, Timonen M, Makela H. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Pediatr Infect Dis J 1986;5:45-50.
6. Borgono JM, McLean AA, Vella PP, et al. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants. Proc Soc Exp Biol Med 1978;157:148-54.
7. Lawrence EM, Edwards KM, Schiffmann G, Thompson JM, Vaughn WK, Wright PF. Pneumococcal vaccine in normal children. Am J Dis Child 1983;137:846-50.
8. Douglas RM, Paton JC, Duncan SJ, Hansman DJ. Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis 1983;148:131-7.
9. Mosier DE, Subbarao B. Thymus-independent antigens: complexicity of B-lymphocyte activation revealed. Immunol Today 1982;3:217-22.
10. Sanders LAM, Rijkers GT, Kuis W, et al. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections. J Allergy Clin Immunol 1993;91:110-9.
11. Ambrosino DM, Siber GR, Chilmonczyk BA, Jernberg JB, Finberg RW. An immunodeficiency characterized by impaired antibody responses to polysaccharides. N Engl J Med 1987;316:790-3.
12. Siber GR, Priehs C, Madore DV. Standardization of antibody assays for measuring the response to pneumococcal infection and immunization. Pediatr Infect Dis J 1989;8: S84-S91.
13. Goldblatt D, Jadresic LP, Levinsky RJ, Turner MW. Antibody responses to pneumococcal capsular polysaccharide: What is being measured? Immunodeficiency 1993;4:47-50.
14. Sullivan JL, Ochs HD, Schiffman G, et al. Immune response after splenectomy. Lancet 1978;1:178-81.
15. Siber GR, Weitzman SA, Aisenberg AC, Weinstein HJ, Schiffman G. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease. N Engl J Med 1978;299:442-8.
16. Minor DR, Schiffman G, McIntosh LS. Response of patients with Hodgkin's disease to pneumococcal vaccine. Ann Intern Med 1979;90:887-92.
17. Giebink GS, Foker JE, Kim Y, Schiffman G. Serum antibody and opsonic response to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children. J Infect Dis 1980;141:404-12.
18. Simberkoff MS, Schiffman G, Katz LA, Spicehandler JR, Moldover NH, Rahal JJ. Pneumococcal capsular polysaccharide vaccination in adult chronic hemodialysis patients. J Lab Clin Med 1980;96:363-70.
19. Lazarius HM, Lederman M, Lubin A, et al. Pneumococcal vaccination: the response of patients with multiple myeloma. Am J Med 1980;69:419-23.
20. Beam TR Jr, Crigler ED, Goldman JK, Schiffman G. Antibody response to polyvalent pneumococcal polysaccharide vaccine in diabetics. JAMA 1980;244:2621-4.
21. Ammann AJ, Schiffman G, Austrian R. The antibody response to pneumococcal capsular polysaccharide in aged individuals. Proc Soc Exp Biol Med 1980;164:312-6.
22. Addiego JE Jr, Ammann AJ, Schiffman G, Bachner R, Higgins G, Hammond D. Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease. Lancet 1980;2:450-2.
23. Ammann AJ, Schiffman G, Abrams D, Volberding P, Ziegler J, Conant M. B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA 1984;251:1447-9.
24. McMahon BJ, Parkinson AJ, Bulkow L, et al. Immunogenicity of the 23-valent pneumococcal polysaccharide in Alaska native chronic alcoholics compared with nonalcoholic native and non-native controls. Am J Med 1993;95:589-94.
25. Mufson MA, Krause HE, Schiffman G. Reactivity and antibody responses of volunteers given two or three doses of pneumococcal vaccine (41934). Proc Soc Exp Biol Med 1984;177:220-5.
26. Mufson MA, Hughey D, Lydick E. Type-specific antibody responses of volunteers immunized with 23-valent pneumococcal polysaccharide vaccine. J Infect Dis 1985;151:749-50.
27. Pirovino M, Lydick E, Grob PJ, Arrenbrecht S, Altorfer J, Schmid M. Pneumococcal vaccination: the response of patients with alcoholic liver cirrhosis. Hepatology 1984;4:946-9.
28. Winston DJ, Ho WG, Schiffman G, Champlin RE, Feig SA, Gale RP. Pneumococcal vaccination of recipients of bone marrow transplants. Arch Intern Med 1983;143:1735-7.
29. Chudwin DS, Artrip SG, Schiffman G. Immunoglobulin G class and subclass antibodies to pneumococcal capsular polysaccharides. Clin Immunol Immunopathol 1987;44:114-21.
30. Barrett DJ, Ammann AJ. Pneumococcal vaccine in sickle cell disease: IgG and IgM antibody response. Rev Infect Dis 1981;3:S179-S182.
31. Ruben FL, Uhrin M. Specific immunoglobulin-class antibody response in the elderly before and after 14-valent pneumococcal vaccine. J Infect Dis 1985;151:845-9.
32. Musher DM, Luchi MJ, Watson DA, Hamilton R, Baughn RE. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effects of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis 1990;161:728-35.
33. Giebink GS, Warkentin PI, Ramsay NKC, Kersey JH. Titers of antibody to pneumococci in allogenic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. J Infect Dis 1986;154:590-6.
34. Birgens HS, Espersen F, Hertz JB, Perdersen FK, Drivsholm A. Antibody response to pneumococcal vaccination in patients with myelomatosis. Scand J Haematol 1983;30:324-30.
35. Frederiksen B, Specht L, Henrichsen J, Pedersen FK, Bjergaard JP. Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease. Eur J Haematol 1989;43:45-9.
36. Hosea SW, Burch CG, Brown EJ, Berg RA, Frank MM. Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine. Lancet 1981;1:804-7.
37. Koskela M, Leinonen M. Comparison of ELISA and RIA for measurement of pneumococcal antibodies before and after vaccination with 14-valent pneumococcal capsular polysaccharide vaccine. J Clin Pathol 1981;34:93-8.
38. Landesman SH, Schiffman G. Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis 1981;3:S184-S196.
39. Immunization Practices Advisory Committee. Pneumococcal polysaccharide vaccine. MMWR 1989;38:64-8, 73-6.
40. Musher DM, Chapman AJ, Goree A, Jonsson S, Briles D, Baughn E. Natural and vaccine related immunity to Streptococcus pneumoniae. J Infect Dis 1986;154:245-56.
41. Sorensen UB, Henrichsen J. C-polysacharride in a pneumococcal vaccine. Acta Pathol Microbiol Immunol Scand 1984;92:351-6.
42. Lee C, Banks SD, Li JP. Virulence, immunity and vaccine related to Streptococcus pneumoniae. Crit Rev Microbiol 1991;18:89-114.
43. Roghmann KJ, Tabloski PA, Bentley DW, Schiffman G. Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment. J Gerontol 1987;42:265-70.
44. Fiebach N, Beckett W. Prevention of respiratory infections in adults: influenza and pneumococcal vaccines. Arch Intern Med 1994;154:2545-57.
45. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453-60.
46. Broome CV, Breiman RF. Pneumococcal vaccine: past, present, and future. N Engl J Med 1991;325:1506-7.
47. Spika JS, Fedson DS, Facklam RR. Pneumococcal vaccination: controversies and opportunities. Infect Dis Clin North Am 1990;4:11-27.
48. Sims RV, Steinmann WC, McConville JH, King LR, Zwick WC, Schwartz S. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med 1988;108:653-7.
49. Fine MJ, Smith MA, Carson CA, et al. Efficacy of pneumococcal vaccination in adults: a meta-analysis of randomized controlled trials. Arch Intern Med 1994;154:2666-77.